Home / Food  / Magadh Sugar Reports ₹1 Crore Profit in Q2 FY27

Magadh Sugar Reports ₹1 Crore Profit in Q2 FY27

Kolkata, West Bengal, November 6, 2026: The Board of Directors of Magadh Sugar & Energy Limited (MSEL) (BSE: 540650 / NSE: MAGADSUGAR) at its meeting held on November 6, 2026, took on record the unaudited

Kolkata, West Bengal, November 6, 2026: The Board of Directors of Magadh Sugar & Energy Limited (MSEL) (BSE: 540650 / NSE: MAGADSUGAR) at its meeting held on November 6, 2026, took on record the unaudited Financial Results for the Quarter ended September 30, 2026.

Financial & Operational Highlights:

Financial Highlights:

Q2FY27

§ Total Income in Q2 FY27 at Rs. 290 Cr as against Rs. 325 Cr in Q2 FY26.

§ EBITDA in Q2 FY27 at Rs. 15 Cr as against Rs. 2 Cr in Q2 FY26.

§ PAT in Q2 FY27 at Rs. 1 Cr as against Rs. (-) 10 Cr in Q2 FY26.

H1FY27

§ Total Income in H1 FY27 at Rs. 602 Cr as against Rs. 659 Cr in H1 FY26.

§ EBITDA in H1 FY27 at Rs. 17 Cr as against Rs. 22 Cr in H1 FY26.

§ PAT in H1 FY27 at Rs. (-) 11 Cr as against Rs. (-) 10 Cr in H1 FY26.

Commenting on the results, Mr. C.S. Nopany, Chairperson, Magadh Sugar & Energy Ltd said:

“Bihar’s sugar industry is witnessing renewed policy support, with the Sugarcane Industry Investment Promotion Policy 2026 aimed at attracting fresh investments, reviving closed mills and modernising integrated sugar, ethanol and co-generation infrastructure.

The broader sugar industry outlook remains favourable, supported by decade-low inventories, expectations of lower production and firm domestic sugar prices. Potential changes in ethanol diversion policies could further influence sugar availability and profitability, while distillery operations remain an important growth driver.

At Magadh, we remain focused on operational efficiency, sugarcane development and optimal utilisation of our integrated assets. Through prudent capital allocation and disciplined execution, we aim to strengthen business resilience and create sustainable long-term value for all stakeholders.”

komal.hospi@gmail.com

Review overview
NO COMMENTS

POST A COMMENT